Kevin Cunningham

Kevin Cunningham is an experienced oncology account manager at Acrotech Biopharma, Inc., specializing in the promotion of histone deacetylase inhibitors for peripheral T-cell lymphoma. With a robust background in pharmaceutical sales, previous roles include CNS Sales Specialist I at Kyowa Kirin, Inc., where Kevin promoted a non-dopaminergic medication for Parkinson’s Disease, and Neuroscience Specialty Representative at Vanda Pharmaceuticals, where an atypical antipsychotic was promoted. Kevin's career also features achievements at Sebela Pharmaceuticals Inc., Pernix Therapeutics, Noven Pharmaceuticals, Merck, and Pfizer, demonstrating consistent sales growth and success in diverse therapeutic areas. Kevin holds a Bachelor of Business Administration in Marketing from Marshall University.